FPR1 and heart disorder: In contrast, a dual FPR1/FPR2 agonist prevented the development of heart disease but failed to correct the lung dysfunction: this was due to an FPR1-mediated recruitment of inflammatory monocytes and concordantly increased numbers of pro-fibrotic CX3CR1+CD11c+SiglecF+MHCIIhi macrophages.